Molecular map of chronic lymphocytic leukemia and its impact on outcome Journal Article


Authors: Knisbacher, B. A.; Lin, Z.; Hahn, C. K.; Nadeu, F.; Duran-Ferrer, M.; Stevenson, K. E.; Tausch, E.; Delgado, J.; Barbera-Mourelle, A.; Taylor-Weiner, A.; Bousquets-Muñoz, P.; Diaz-Navarro, A.; Dunford, A.; Anand, S.; Kretzmer, H.; Gutierrez-Abril, J.; López-Tamargo, S.; Fernandes, S. M.; Sun, C.; Sivina, M.; Rassenti, L. Z.; Schneider, C.; Li, S.; Parida, L.; Meissner, A.; Aguet, F.; Burger, J. A.; Wiestner, A.; Kipps, T. J.; Brown, J. R.; Hallek, M.; Stewart, C.; Neuberg, D. S.; Martín-Subero, J. I.; Puente, X. S.; Stilgenbauer, S.; Wu, C. J.; Campo, E.; Getz, G.
Article Title: Molecular map of chronic lymphocytic leukemia and its impact on outcome
Abstract: Recent advances in cancer characterization have consistently revealed marked heterogeneity, impeding the completion of integrated molecular and clinical maps for each malignancy. Here, we focus on chronic lymphocytic leukemia (CLL), a B cell neoplasm with variable natural history that is conventionally categorized into two subtypes distinguished by extent of somatic mutations in the heavy-chain variable region of immunoglobulin genes (IGHV). To build the ‘CLL map,’ we integrated genomic, transcriptomic and epigenomic data from 1,148 patients. We identified 202 candidate genetic drivers of CLL (109 new) and refined the characterization of IGHV subtypes, which revealed distinct genomic landscapes and leukemogenic trajectories. Discovery of new gene expression subtypes further subcategorized this neoplasm and proved to be independent prognostic factors. Clinical outcomes were associated with a combination of genetic, epigenetic and gene expression features, further advancing our prognostic paradigm. Overall, this work reveals fresh insights into CLL oncogenesis and prognostication. © 2022, The Author(s), under exclusive licence to Springer Nature America, Inc.
Keywords: genetics; mutation; pathology; immunoglobulin variable region; genomics; chronic lymphatic leukemia; leukemia, lymphocytic, chronic, b-cell; humans; prognosis; human
Journal Title: Nature Genetics
Volume: 54
Issue: 11
ISSN: 1061-4036
Publisher: Nature Publishing Group  
Date Published: 2022-11-01
Start Page: 1664
End Page: 1674
Language: English
DOI: 10.1038/s41588-022-01140-w
PUBMED: 35927489
PROVIDER: scopus
PMCID: PMC10084830
DOI/URL:
Notes: Article -- Export Date: 1 December 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors